Dr. Bachier on the Evolution of Stem Cell Transplants in Hematologic Malignancies – OncLive
OncLive |
Dr. Bachier on the Evolution of Stem Cell Transplants in Hematologic Malignancies
OncLive Carlos R. Bachier, MD, director, blood and marrow transplant research, Sarah Cannon Research Institute, discusses the advancement of supportive care in hematologic malignancies. Fifty years ago, bone marrow was the source of stem cells. Now, stem cells … |
